WEST PHARMACEUTICAL SERVICES, INC. Current Income Tax Expense (Benefit)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Current Income Tax Expense (Benefit) of $135.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for the quarter ending 2016-12-31 was $24.80M.
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for the quarter ending 2016-09-30 was $700.00K.
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for the quarter ending 2016-06-30 was $15.30M.
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for the quarter ending 2016-03-31 was -$7.90M.
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for fiscal 2025 was $135.30M, a 21.89% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for fiscal 2024 was $111.00M, a 30.90% increase from fiscal 2023.
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for fiscal 2023 was $84.80M, a 41.72% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. current income tax expense (benefit) for fiscal 2022 was $145.50M, a 3.06% decline from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $135.30M 10-K · filed 2026-02-17 | |||
| 2024-12-31 | $111.00M 10-K · filed 2026-02-17 | |||
| 2023-12-31 | $84.80M 10-K · filed 2026-02-17 | |||
| 2022-12-31 | $145.50M 10-K · filed 2025-02-18 | |||
| 2021-12-31 | $150.10M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | $78.30M 10-K · filed 2023-02-21 | |||
| 2019-12-31 | $43.70M 10-K · filed 2022-02-22 | |||
| 2018-12-31 | $40.50M 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $39.20M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $24.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $25.50M derived: sum of 2 quarters · filed 2019-02-28 | $40.80M derived: sum of 3 quarters · filed 2019-02-28 | $32.90M 10-K · filed 2019-02-28 |
| 2016-09-30 | $700.00K 10-Q · filed 2016-10-31 | $16.00M derived: sum of 2 quarters · filed 2016-10-31 | $8.10M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $15.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $7.40M 10-Q · filed 2016-08-01 | ||
| 2016-03-31 | -$7.90M 10-Q · filed 2016-05-06 | |||
| 2015-12-31 | $35.20M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $40.20M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $38.50M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $27.40M 10-K · filed 2015-02-25 | |||
| 2011-12-31 | $20.60M 10-K · filed 2014-02-27 | |||
| 2010-12-31 | $15.40M 10-K · filed 2013-02-27 | |||
| 2009-12-31 | $18.30M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |